ADMA BIOLOGICS, INC. Interest Payable, Current
ADMA BIOLOGICS, INC. (ADMA) had Interest Payable, Current of $122.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2026-08-05
- 2026-06-30: Interest Payable, Current $122.00K.
- 2026-03-31: Interest Payable, Current $750.00K.
- 2025-12-31: Interest Payable, Current $172.00K.
- 2025-09-30: Interest Payable, Current $105.00K.
| Period end | Interest Payable, Current |
|---|---|
| 2026-06-30 | $122.00K 10-Q · filed 2026-08-05 |
| 2026-03-31 | $750.00K 10-Q · filed 2026-05-06 |
| 2025-12-31 | $172.00K 10-Q · filed 2026-08-05 |
| 2025-09-30 | $105.00K 10-Q · filed 2025-11-05 |
| 2025-06-30 | $1.27M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $1.89M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $2.86M 10-K · filed 2026-02-25 |
| 2024-09-30 | $3.45M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $3.77M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $3.48M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $546.00K 10-K · filed 2025-03-18 |
| 2015-12-31 | $0.00 10-K · filed 2016-03-23 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-10 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-11 |
| 2015-03-31 | $114.72K 10-Q · filed 2015-05-12 |
| 2014-12-31 | $105.66K 10-K · filed 2016-03-23 |
| 2014-09-30 | $73.67K 10-Q · filed 2014-11-10 |
| 2014-06-30 | $142.27K 10-Q · filed 2014-08-11 |
| 2014-03-31 | $101.10K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $36.60K 10-K · filed 2015-03-09 |
| 2013-09-30 | $35.42K 10-Q · filed 2013-11-12 |
| 2013-06-30 | $35.42K 10-Q · filed 2013-08-12 |
| 2013-03-31 | $33.29K 10-Q · filed 2013-05-14 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-28 |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-13 |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-15 |
| 2011-12-31 | $10.78K 10-Q · filed 2012-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |